• About us
    • Successful cases
    • R+D
    • Clients
    • News
  • Particle
    technologies
  • Particle characterization
    • Services
      • Development and validation of PSD methods
      • Determination of accuracy of PSD methods
      • Particle morphological characterization
      • Solid state and crystallographic studies
      • Nano-Characterization
      • Analytical Development
    • Analysis
      • Granulometry - PSD
        • Laser Diffraction
        • Automated Optical Microscopy
      • Particle Morphology
        • Automated Optical Microscopy
        • Electron Microscopy
      • Nanoparticle Analysis
        • Dynamic Light Scattering
        • CRYO-TEM
      • Chemical Composition
        • HPLC (High-Performance Liquid Chromatography)
        • Image Analysis from Optical and Electron Microscopy
    • Quality
    • Case Studies
      • Analytical support into raw materials supplier qualification
      • Analytical investigation on OOS samples
      • Analytical investigation to support IP and regulatory procedures
      • Characterisation of nanostructures and nanoformulations
      • Comparison between development/test samples and Reference Drug Product/RLD samples
      • Image analysis studies from optical and electron microscopy
  • Contact us
Back to the gallery

News

Lídia Ballell, R&D Scientist of Nanomol Technologies, Poster Prize at the SCN2 II Annual Conference of Nanomedicine
20 November 2020

Lídia Ballell, R&D Scientist of Nanomol Technologies, Poster Prize at the SCN2 II Annual Conference of Nanomedicine

Lídia Ballell, R&D Scientist of Nanomol Technologies, won the Poster Prize award at the SCN2 II Annual Conference of Nanoscience and Nanotechnology celebrated on 19 November 2020 and focused on the latest advances on nanobiomedicine. Lidia Ballell is a PhD fellow doing her research between Nanomol Technologies and the Nanomol Group at the Institute of Materials Science of Barcelona (ICMAB-CSIC).

Lídia Ballell's poster was entitled "DELOS nanovesicles for drug delivery: an example of reformulation of a protein to treat complex wounds". 

Related
news

Engineering pH-Sensitive Stable Nanovesicles for Delivery of MicroRNA Therapeutics 22 December 2021

Engineering pH-Sensitive Stable Nanovesicles for Delivery of MicroRNA Therapeutics

PHOENIX OITB gGmbH: Pioneering Nano-Pharmaceutical Innovation  27 February 2024

PHOENIX OITB gGmbH: Pioneering Nano-Pharmaceutical Innovation 

PHOENIX-OITB Launches 2nd Round of its Open Call Offering Funded Services in Nanopharmaceutical Development 08 April 2024

PHOENIX-OITB Launches 2nd Round of its Open Call Offering Funded Services in Nanopharmaceutical Development

come and visit us

NANOMOL TECHNOLOGIES, S.L.
Mòdul de Recerca B
UAB CAMPUS

08193 Bellaterra
Cerdanyola del Vallès
Barcelona
Spain

get in touch

T +34 935 868 963
INFO@NANOMOL-TECH.COM

follow us

Twitter Linkedin

terms of use

Privacy policy Legality Cookies

Copyright © 2026

Nanomol Technologies S.L.

Site by Suki